Optibiotix Health

OptiBiotix Health PLC, formerly Ducat Ventures PLC, is a United Kingdom-based life sciences company developing compounds to tackle obesity, high cholesterol and diabetes. The Company develops a range of compounds which modify the human microbiome (the collective genome of the microbes in the body), to prevent and manage human disease. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The product development pipeline is fuelled by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds. These platforms are applicable across a range of other human diseases.
Type
Public
HQ
Heslington, GB
Size (employees)
5 (est)
Optibiotix Health is headquartered in Heslington, GB

Optibiotix Health Office Locations

Optibiotix Health has an office in Heslington
Heslington, GB (HQ)
Innovation Way

Optibiotix Health Financials and Metrics

Optibiotix Health Financials

Optibiotix Health's revenue was reported to be £288.1 k in FY, 2016 which is a 922% increase from the previous period.
GBP

Revenue (FY, 2016)

288.1 k

Revenue growth (FY, 2015 - FY, 2016), %

922%

Gross profit (FY, 2016)

249.9 k

Gross profit margin (FY, 2016), %

87%

Net income (FY, 2016)

(1.3 m)

EBITDA (FY, 2016)

(1.4 m)

EBIT (FY, 2016)

(1.5 m)

Market capitalization (31-Oct-2017)

55.4 m

Closing share price (31-Oct-2017)

0.7

Cash (30-Nov-2016)

3.1 m
Optibiotix Health's current market capitalization is £55.4 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.3 k161.6 k28.2 k288.1 k

Revenue growth, %

922%

Cost of goods sold

257.2 k38.2 k

Gross profit

(95.6 k)249.9 k
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

870.9 k819.7 k779.3 k13.5 k27.6 k1502.9 m2 m3.1 m

Accounts Receivable

16.6 k111.5 k4.7 k62.6 k

Inventories

48.2 k340.9 k26.6 k

Current Assets

875.6 k822.2 k782.9 k113.3 k480.1 k301.4 k2.9 m2.2 m3.5 m
    GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (31.8 k)(15.6 k)(36.3 k)(256.4 k)(1.7 m)(2.2 m)(810.7 k)(1.3 m)(1.3 m)

    Cash From Operating Activities

    27.6 k(63.1 k)(42.3 k)(195.2 k)(1.1 m)(502.4 k)(680.5 k)(983.5 k)(1.2 m)

    Purchases of PP&E

    (1.1 k)(2 k)

    Cash From Investing Activities

    250.7 k(2 k)
      Y, 2016

      Financial Leverage

      1.2 x
      Show all financial metrics

      Optibiotix Health Operating Metrics

      H1, 2016

      Patents Issued

      44

      Patents and Patent Applications

      14
      Show all operating metrics

      Optibiotix Health Market Value History

      Optibiotix Health's Web-traffic and Trends

      Optibiotix Health Online and Social Media Presence

      Optibiotix Health Company Life and Culture

      You may also be interested in